Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-031670

President and CEO sold 19,488 shares at an average $8.41 ($163,893)

  • President and CEO acquired 43,028 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KANE MATTHEW R. · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-07 Exercise or conversion : show line 1 in the form +21,514 $0.04 $861 1,999,732 D
2021-05-07 Sale : show line 2 in the form −9,742 $8.57 $83,489 1,989,990 D
2021-05-10 Exercise or conversion : show line 3 in the form +21,514 $0.04 $861 2,011,504 D
2021-05-10 Sale : show line 4 in the form −9,746 $8.25 $80,405 2,001,758 D
Open-market sales · 19,488 sh · avg $8.41 · $163,893

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-05-07 Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) −21,514 43,028 D
2021-05-10 Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) −21,514 21,514 D
Loading xslF345X03/doc4.xml…